Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study). (academic.oup.com)

Authors: Serrano-Villar S … Moreno S Journal: Clinical Infectious Diseases Published: 2026-02-25 DOI: https://doi.org/10.1093/cid/ciaf565